Author

C. Imbusch

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Assay:DNA methylation· 1

Frequent Co-Authors

B. Brors· 3 shared A. Sedlmeier· 1 shared A. Trumpp· 1 shared A. Warth· 1 shared B. Durie· 1 shared B. Jung· 1 shared B. Mardin· 1 shared C. Keller· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

B. Brors

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Multiple myeloma long-term survivors display sustained immune alterations decades after first line therapy

R. Lutz, F. Gruenschlaeger, M. Simon, M. Bauer, S. Yousefian, N. Beumer, L. Jopp-Saile, M. Awwad, G. Steinbuss, A. Sedlmeier, T. Boch, D. Vonficht, M.-A. Baertsch, B. Durie, N. Weinhold, , S. Haas

This study examines immune changes in multiple myeloma survivors years after treatment, finding sustained immune alterations linked to residual disease and therapy.

bioRxiv · May 27, 2023 · PreprintCancer Biology

Chronic chromosome instability induced by Plk1 results in immune suppression in breast cancer

S. Kandala, L. Voith von Voithenberg, S. Chocarro, M. Ramos, J. Keding, B. Brors, C. Imbusch, R. Sotillo

This study shows that Plk1-induced chronic chromosome instability in breast cancer leads to immune suppression through RELB signaling and PD-L1 upregulation.

bioRxiv · Jun 16, 2022Cancer Biology

High-resolution epigenetic profiling identifies novel regulators of COPD in human lung fibroblasts

U. Schwartz, M. Llamazares Prada, S. T. Pohl, M. Richter, R. Tamas, M. Schuler, C. Keller, V. Mijosek, T. Muley, M. A. Schneider, K. Quast, J. Hey, C. P. Heussel, A. Warth, H. Winter, , R. Jurkowska

This study identifies novel epigenetic and transcriptomic regulators of COPD in human lung fibroblasts across disease stages.

bioRxiv · Mar 28, 2022 · PreprintCell Biology